Lennart is a Senior Advisor with broad experience from leading positions in venture capital. He has been working with pharmaceutical and business development in biotech and pharma companies such as KabiGen, AstraZeneca, Biovitrum, and also held the position as CEO at Arexis. 

Lennart headed the Life Science team at Industrifonden between 2008-2016. He has been on  more than 30 company boards and is the co-founder of two pharmaceutical start-ups. Current assignments include Chairmain of the Board positions at Sixera Pharma, Ignitus, Cinclus Pharma Holding, QureTech Bio AB and Omnio AB. He is also a board member at Medivir (publ). 

Lennart holds a PhD in Genetics from the University of Umeå.